These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [New strategies in the immunotherapy of autoimmune diseases]. Lorenz HM; Geiler T Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778 [No Abstract] [Full Text] [Related]
6. [The current outlook in the therapy of autoimmune diseases]. Sebastiani GD; Passiu G Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130 [TBL] [Abstract][Full Text] [Related]
7. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Williams RO; Paleolog E; Feldmann M Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887 [TBL] [Abstract][Full Text] [Related]
8. Making anti-cytokine therapy more selective: Studies in mice. Drutskaya MS; Efimov GA; Astrakhantseva IV; Kruglov AA; Nedospasov SA Cytokine; 2018 Jan; 101():33-38. PubMed ID: 27624866 [TBL] [Abstract][Full Text] [Related]
9. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?]. Fenner H Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686 [TBL] [Abstract][Full Text] [Related]
11. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Feldmann M; Maini RN Nat Med; 2003 Oct; 9(10):1245-50. PubMed ID: 14520364 [No Abstract] [Full Text] [Related]
12. [Monoclonal antibodies in chronic autoimmune inflammatory diseases]. Semerano L; Boissier MC Med Sci (Paris); 2009 Dec; 25(12):1108-12. PubMed ID: 20035687 [TBL] [Abstract][Full Text] [Related]
13. Cytokines and autoimmunity. O'Shea JJ; Ma A; Lipsky P Nat Rev Immunol; 2002 Jan; 2(1):37-45. PubMed ID: 11905836 [TBL] [Abstract][Full Text] [Related]
14. Immunological therapies for rheumatoid arthritis. Edwards CJ Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines. Karin N Isr Med Assoc J; 2000 Jul; 2 Suppl():63-8. PubMed ID: 10909420 [TBL] [Abstract][Full Text] [Related]
16. Design of effective immunotherapy for human autoimmunity. Feldmann M; Steinman L Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214 [TBL] [Abstract][Full Text] [Related]
17. B lymphocytes are required for development and treatment of autoimmune diseases. Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517 [TBL] [Abstract][Full Text] [Related]
18. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt? Jorgensen C; Apparailly F; Sany J Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909 [No Abstract] [Full Text] [Related]
19. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer. Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900 [TBL] [Abstract][Full Text] [Related]
20. [Kinoids: a novel generation of specific immune therapy against cytokines]. Bensussan A; Bizzini B; Pouletty P; Gallo RC; Zagury D Med Sci (Paris); 2008 Mar; 24(3):306-13. PubMed ID: 18334181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]